THE MISSION OF DNDI NORTH AMERICA IS TO CONTRIBUTE TO THE ACHIEVEMENT OF DNDI'S GLOBAL OBJECTIVES, IN PARTICULAR TO STRENGHTEN AND EXPAND DNDI'S SCIENTIFIC, POLICY ADVOCACY, FUNDRAISING, AND COMMUNICATIONS EFFORTS IN NORTH AMERICA BY (A) PROVIDING FOCUSED SUPPORT FOR SPECIFIC R&D PROJECTS AND BUSINESS/PARTNER DEVELOPMENT ACTIVITIES IN NORTH AMERICA;(B) ACHIEVING CONCRETE POLICY CHANGES IN NORTH AMERICA TO CREATE A MORE FAVORABLE ENVIRONMENT FOR NEEDS-DRIVEN R&D FOR NEGLECTED DISEASES;(C) MOBILIZING PUBLIC AND PRIVATE FUNDS IN NORTH AMERICA TO SUPPORT DNDI'S MISSION;(D) INCREASING DNDI'S PROFILE AND VISIBILITY IN NORTH AMERICA, THEREBY DRAWING GREATER PUBLIC ATTENTION TO THE NEED FOR NEGLECTED DISEASE R&D.
Executive compensation, broken down
Form 990 · Part VII & Schedule J · 6 reported individuals · Filing year 2024
Percentile bands compare each position's total pay with the same role at Health Care organizations in New York.
- Base
- $240k
- Bonus
- —
- Other
- —
- Benefits
- $50k
- Base
- $213k
- Bonus
- —
- Other
- —
- Benefits
- $50k
- Base
- $146k
- Bonus
- —
- Other
- —
- Benefits
- $23k
- Base
- $156k
- Bonus
- —
- Other
- —
- Benefits
- —
- Base
- $123k
- Bonus
- —
- Other
- —
- Benefits
- $17k
- Base
- $107k
- Bonus
- —
- Other
- —
- Benefits
- $35k
| Position | Base | Bonus | Other | Benefits | Total |
|---|---|---|---|---|---|
Executive Director Median to 75th percentile | $240k | — | — | $50k | $311k $336k |
Senior Advisor, Global Pol Officer (Unspecified) | $213k | — | — | $50k | $282k $305k |
Senior Clinical Project an Highest Compensated Employee 10th to 25th percentile | $146k | — | — | $23k | $177k $192k |
Head of Media and Content Highest Compensated Employee 10th to 25th percentile | $156k | — | — | — | $170k $184k |
Senior Individual Giving Manager Highest Compensated Employee 10th to 25th percentile | $123k | — | — | $17k | $152k $164k |
Senior HR Business Partner Highest Compensated Employee 10th to 25th percentile | $107k | — | — | $35k | $151k $163k |
Teal figures restate each filed amount in 2026 dollars.
Estimated with New York-Newark-Jersey City, NY-NJ-PA metro-area CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.
Plus 8 unpaid individuals.
Top pay as a share of expenses
In 2024, the highest total compensation at DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA INC equaled 5% of the organization's total expenses. The median for health care organizations is 4%.
Based on 13,830 health care organizations, each measured at its most recent filing year with reported expenses and compensation.
Funded by
Private foundations whose Form 990-PF Part XV grants matched this organization.
Up 13%
from 2023
From $275k in 2023 to $311k in 2024.
Estimated with New York-Newark-Jersey City, NY-NJ-PA metro-area CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.
Highest Compensated Employee pay rose 6% from 2023 to 2024, while revenue rose 43%.
Pay for the position itself, not any one person. The officeholder may have changed between 2023 and 2024.
Among peers
Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.
Common questions about DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA INC
What does the Chief Executive Officer of DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA INC earn?
In 2024, the Chief Executive Officer of DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA INC received $310,984 in total compensation. This pay is above the median (the midpoint) for Chief Executive Officer roles among Health Care organizations in New York, within the top half of comparable filings. Based on IRS Form 990 data.
How does Chief Executive Officer pay at DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA INC compare with similar nonprofits?
Compared with the same role at Health Care organizations in New York, the 2024 pay of the Chief Executive Officer at DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA INC falls between the median and the 75th percentile. In 2024, the highest total compensation at DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA INC equaled 5% of the organization's total expenses. The median for health care organizations is 4%.
What are DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA INC's revenue and expenses?
In 2024, DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA INC reported $6.2M in total revenue and $6.3M in total expenses on its IRS Form 990.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.
Learn More About Nonprofit Compensation
Guides to help you understand and use this data
Nonprofit Executive Director Salary
What nonprofit executive directors earn, what drives the number, and how to use public compensation data whether you are a candidate, a current ED, or a board member.
Read moreHow to Look Up Nonprofit Salaries
Two approaches to finding executive compensation at any tax-exempt organization, from raw IRS filings to searchable databases.
Read moreAre Nonprofit Salaries Public?
What IRS Form 990 discloses about executive compensation, who has to report it, and how to look it up.
Read more